Few NMP organoids displayed enriched EMT, TGF-beta signaling, and KRAS signaling up pathways, which seemingly contradicts their associations with invasive tumor features typically observed in more aggressive, metastatic cancers. The gene discussed is KRAS; the disease is metastatic malignant neoplasm.